Review Article

Management of Patients with Allergic Rhinitis and Asthma: Literature Review

Authors: Robert A. Nathan MD

Abstract

Abstract:Allergic rhinitis (AR) and asthma are disorders of the airway characterized by inflammation of the respiratory mucosa. The presence of one disorder increases the likelihood that the other will also occur. As they are mechanistically intertwined, one can exacerbate the other when both conditions are present. In addition, comorbid AR and asthma have an additive impact on patients’ health-related quality of life. The Allergic Rhinitis and its Impact on Asthma (ARIA) recommendations suggest that asthma patients should be evaluated for AR, and all AR patients should undergo tests for asthma. They also suggest that ideally, a combined strategy should be used to treat the upper and lower airway diseases. While treatment for AR includes antihistamines, intranasal glucocorticosteroids, antileukotrienes, and specific immunotherapy, data suggest that these treatment approaches may also improve asthma outcomes. This article reviews current clinical approaches to the diagnosis and management of patients with comorbid AR and asthma.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

References1.Gaugris S, Sazonov-Kocevar V, Thomas M. Burden of concomitant allergic rhinitis in adults with asthma. J Asthma 2006;43:1–7.GaugrisS]]Sazonov-KocevarV]]ThomasMBurden of concomitant allergic rhinitis in adults with asthma.J Asthma2006431-72.Bachert C, van Cauwenberge P, Khaltaev N; World Health Organization. Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7–10 December 1999, Geneva, Switzerland. Allergy 2002;57:841–855.BachertC]]van CauwenbergeP]]KhaltaevNWorld Health OrganizationAllergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7–10 December 1999, Geneva, Switzerland.Allergy200257841-8553.Bousquet J, Van Cauwenberge P, Khaltaev N; ARIA Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(suppl 5):S147–S334.BousquetJ]]Van CauwenbergeP]]KhaltaevNARIA Workshop GroupWorld Health OrganizationAllergic rhinitis and its impact on asthma.J Allergy Clin Immunol2001108S147-S3344.Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA). Available at: http://www.ginasthma.com/Guidelineitem.asp?l1=2&l2=1&intId=60. Accessed September 16, 2008.5.Bloom B, Cohen RA. Summary health statistics for U.S. children: National Health Interview Survey, 2006. Vital Health Stat 10 2007;234:1–79.BloomB]]CohenRASummary health statistics for U.S. children: National Health Interview Survey, 2006.Vital Health Stat 1020072341-796.Pleis JR, Lethbridge-Cejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2006. Vital Health Stat 10 2007;235:1–153.PleisJR]]Lethbridge-CejkuMSummary health statistics for U.S. adults: National Health Interview Survey, 2006.Vital Health Stat 1020072351-1537.Meng YY, Babey SH, Hastert TA, et al. Uncontrolled asthma means missed work and school, emergency department visits for many Californians. Policy Brief UCLA Cent Health Policy Res 2008;PB2008–2:1–8.8.Guerra S, Sherrill DL, Martinez FD, et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002;109:419–425.GuerraS]]SherrillDL]]MartinezFD&etal;Rhinitis as an independent risk factor for adult-onset asthma.J Allergy Clin Immunol2002109419-4259.Navarro A, Valero A, Juliá B, et al. Coexistence of asthma and allergic rhinitis in adult patients attending allergy clinics: ONEAIR study. J Investig Allergol Clin Immunol 2008;18:233–238.NavarroA]]ValeroA]]JuliáB&etal;Coexistence of asthma and allergic rhinitis in adult patients attending allergy clinics: ONEAIR study.J Investig Allergol Clin Immunol200818233-23810.Leynaert B, Neukirch F, Demoly P, et al. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000;106:S201–S205.LeynaertB]]NeukirchF]]DemolyP&etal;Epidemiologic evidence for asthma and rhinitis comorbidity.J Allergy Clin Immunol2000106S201-S20511.Rusconi F, Galassi C, Corbo GM, et al. Risk factors for early, persistent, and late-onset wheezing in young children. SIDRIA Collaborative Group. Am J Respir Crit Care Med 1999;160(5 pt 1):1617–1622.RusconiF]]GalassiC]]CorboGM&etal;Risk factors for early, persistent, and late-onset wheezing in young children. SIDRIA Collaborative Group.Am J Respir Crit Care Med19991605 pt 11617-162212.Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008;372:1049–1057.ShaabanR]]ZureikM]]SoussanD&etal;Rhinitis and onset of asthma: a longitudinal population-based study.Lancet20083721049-105713.Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994;15:21–25.SettipaneRJ]]HagyGW]]SettipaneGALong-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students.Allergy Proc19941521-2514.Halpern MT, Schmier JK, Richner R, et al. Allergic rhinitis: a potential cause of increased asthma medication use, costs, and morbidity. J Asthma 2004;41:117–126.HalpernMT]]SchmierJK]]RichnerR&etal;Allergic rhinitis: a potential cause of increased asthma medication use, costs, and morbidity.J Asthma200441117-12615.Magnan A, Meunier JP, Saugnac C, et al. Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study. Allergy 2008;63:292–298.MagnanA]]MeunierJP]]SaugnacC&etal;Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study.Allergy200863292-29816.Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy 2003;58:691–706.BousquetJ]]VignolaAM]]DemolyPLinks between rhinitis and asthma.Allergy200358691-70617.Jeffery PK, Haahtela T. Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med 2006;6(suppl 1):S5.JefferyPK]]HaahtelaTAllergic rhinitis and asthma: inflammation in a one-airway condition.BMC Pulm Med20066S518.Humbles AA, Lloyd CM, McMillan SJ, et al. A critical role for eosinophils in allergic airways remodeling. Science 2004;305:1776–1779.HumblesAA]]LloydCM]]McMillanSJ&etal;A critical role for eosinophils in allergic airways remodeling.Science20043051776-177919.Saglani S, Malmström K, Pelkonen AS, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005;171:722–727.SaglaniS]]MalmströmK]]PelkonenAS&etal;Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction.Am J Respir Crit Care Med2005171722-72720.Meltzer EO. The relationships of rhinitis and asthma. Allergy Asthma Proc 2005;26:336–340.MeltzerEOThe relationships of rhinitis and asthma.Allergy Asthma Proc200526336-34021.Ciprandi G, Cirillo I, Vizzaccaro A, et al. Early bronchial airflow impairment in patients with persistent allergic rhinitis and bronchial hyperreactivity. Respir Med 2005;99:1606–1612.CiprandiG]]CirilloI]]VizzaccaroA&etal;Early bronchial airflow impairment in patients with persistent allergic rhinitis and bronchial hyperreactivity.Respir Med2005991606-161222.Ciprandi G, Cirillo I, Pistorio A, et al. Impact of allergic rhinitis on asthma: effects on bronchodilation testing. Ann Allergy Asthma Immunol 2008;101:42–46.CiprandiG]]CirilloI]]PistorioA&etal;Impact of allergic rhinitis on asthma: effects on bronchodilation testing.Ann Allergy Asthma Immunol200810142-4623.Crystal-Peters J, Neslusan C, Crown WH, et al. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002;109:57–62.Crystal-PetersJ]]NeslusanC]]CrownWH&etal;Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits.J Allergy Clin Immunol200210957-6224.Grant JA, Nicodemus CF, Findlay SR, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995;95:923–932.GrantJA]]NicodemusCF]]FindlaySR&etal;Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial.J Allergy Clin Immunol199595923-93225.Baena-Cagnani CE, Berger WE, DuBuske LM, et al. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol 2003;130:307–313.Baena-CagnaniCE]]BergerWE]]DuBuskeLM&etal;Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma.Int Arch Allergy Immunol2003130307-31326.Pasquali M, Baiardini I, Rogkakou A, et al. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy 2006;36:1161–1167.PasqualiM]]BaiardiniI]]RogkakouA&etal;Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters.Clin Exp Allergy2006361161-116727.Bachert C, Bousquet J, Canonica GW, et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 2004;114:838–844.BachertC]]BousquetJ]]CanonicaGW&etal;Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.J Allergy Clin Immunol2004114838-84428.Bachert C, Demarteau N. Levocetirizine reduces asthma comorbidity in patients with persistent allergic rhinitis: An exploratory analysis of the XPERT trial [abstract 238]. J World Allergy Org 2005;1:100–101.BachertC]]DemarteauNLevocetirizine reduces asthma comorbidity in patients with persistent allergic rhinitis: An exploratory analysis of the XPERT trial [abstract 238].J World Allergy Org20051100-10129.Corren J, Harris AG, Aaronson D, et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 1997;100:781–788.CorrenJ]]HarrisAG]]AaronsonD&etal;Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma.J Allergy Clin Immunol1997100781-78830.Nathan RA, Finn AF Jr, LaForce C, et al. Comparison of cetirizine-pseudoephedrine and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma: randomized, double-blind study. Ann Allergy Asthma Immunol 2006;97:389–396.NathanRA]]FinnAFJr]]LaForceC&etal;Comparison of cetirizine-pseudoephedrine and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma: randomized, double-blind study.Ann Allergy Asthma Immunol200697389-39631.Nathan RA, Kemp JP; Antileukotriene Working Group. Efficacy of antileukotriene agents in asthma management. Ann Allergy Asthma Immunol 2001;86:9–17.NathanRA]]KempJPAntileukotriene Working GroupEfficacy of antileukotriene agents in asthma management.Ann Allergy Asthma Immunol2001869-1732.Philip G, Nayak AS, Berger WE, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004;20:1549–1558.PhilipG]]NayakAS]]BergerWE&etal;The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis.Curr Med Res Opin2004201549-155833.Busse WW, Casale TB, Dykewicz MS, et al. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity. Ann Allergy Asthma Immunol 2006;96:60–68.BusseWW]]CasaleTB]]DykewiczMS&etal;Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.Ann Allergy Asthma Immunol20069660-6834.Bousquet J, van Cauwenberge P, Ait Khaled N, et al; GA2LEN. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy 2006;61:1086–1096.BousquetJ]]van CauwenbergeP]]Ait KhaledN&etal;GA2LENPharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN).Allergy2006611086-109635.Adams RJ, Fuhlbrigge AL, Finkelstein JA, et al. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 2002;109:636–642.AdamsRJ]]FuhlbriggeAL]]FinkelsteinJA&etal;Intranasal steroids and the risk of emergency department visits for asthma.J Allergy Clin Immunol2002109636-64236.Nathan RA, Yancey SW, Waitkus-Edwards K, et al. Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest 2005;128:1910–1920.NathanRA]]YanceySW]]Waitkus-EdwardsK&etal;Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.Chest20051281910-192037.Casale TB, Condemi J, LaForce C, et al; Omalizumab Seasonal Allergic Rhinitis Trail Group. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. JAMA 2001;286:2956–2967.CasaleTB]]CondemiJ]]LaForceC&etal;Omalizumab Seasonal Allergic Rhinitis Trail GroupEffect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.JAMA20012862956-296738.Vignola AM, Humbert M, Bousquet J, et al. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy 2004;59:709–717.VignolaAM]]HumbertM]]BousquetJ&etal;Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.Allergy200459709-71739.Jacobsen L, Nũchel Petersen B, Wihl JA, et al. Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up. Allergy 1997;52:914–920.JacobsenL]]Nũchel PetersenB]]WihlJA&etal;Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up.Allergy199752914-92040.Jacobsen L, Niggemann B, Dreborg S, et al; The PAT Investigator Group. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007;62:943–948.JacobsenL]]NiggemannB]]DreborgS&etal;The PAT Investigator GroupSpecific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.Allergy200762943-94841.Kopp MV, Hamelmann E, Zielen S, et al; DUAL Study Group. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma. Clin Exp Allergy 2009;39:271–279.KoppMV]]HamelmannE]]ZielenS&etal;DUAL Study GroupCombination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.Clin Exp Allergy200939271-27942.Bousquet J, Khaltaev N, Cruz AA, et al; World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(suppl 86):8–160.BousquetJ]]KhaltaevN]]CruzAA&etal;World Health OrganizationGA(2)LENAllerGenAllergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).Allergy2008638-160